/ ajpgi.00456.2003.-Hepatic uptake of bile acids is mediated by the Na ϩ -taurocholate cotransporting polypeptide (NTCP; SLC10A1) of the basolateral hepatocyte membrane. Several cis-acting elements in the rat Ntcp gene promoter have been characterized. However, little is known about the mechanisms that control the expression of the human or mouse NTCP/Ntcp. We, therefore, compared the transcriptional regulation of the human and mouse NTCP/Ntcp gene with that of the rat. By computer alignment, a sequence in the 5Ј-regulatory region that is conserved between species was identified near the transcription start site. Huh7 cells were transfected with luciferase constructs containing the conserved region from each species. The hepatocyte nuclear factors (HNF)1␣ and -4␣ and the retinoid X receptor/ retinoic acid receptor dimer (RXR␣/RAR␣) bound and transactivated the rat but not the human or mouse NTCP/Ntcp promoters. In contrast, activation by the CCAAT/enhancer binding protein-␤ was specific for human and mouse NTCP/Ntcp. The only consensus motif present in all three species was HNF3␤. HNF3␤ formed a specific DNA-protein complex in electrophoretic mobility shift assays and inhibited NTCP/Ntcp promoter activity in cotransfection assays. Finally, a minor repressive effect of bile acids was only found for rat Ntcp. The transcriptional repressor small heterodimer partner (SHP) did not affect NTCP/Ntcp promoter activity. We conclude that 1) the transcriptional regulation of the conserved NTCP/Ntcp 5Ј-regulatory region differs considerably among human, mouse, and rat; and 2) the conserved NTCP/Ntcp regulatory region is not directly regulated by SHP. Bile acids may regulate NTCP/Ntcp indirectly by modulating the capacity of nuclear factors to activate gene expression. organic anion transport; bile acids and salts;
THE MAJOR DRIVING FORCE FOR bile excretion is the active vectorial transport of bile salts from blood into bile. In mammalian liver, the Na ϩ -taurocholate cotransporting polypeptide (NTCP in humans, Ntcp in rodents; gene symbol SLC10A1/Slc10a1) accounts for Ͼ80% of conjugated bile acid uptake across the basolateral membrane of hepatocytes (24, 36) . The NTCP/Ntcp gene, which is highly conserved between species (16) , is subject to extensive regulation under conditions such as pregnancy, cholestasis, and sepsis (24, 36, 40) . Any disturbance in bile excretion leads to the accumulation of bile acids in hepatocytes and cholestatic liver damage. An early defense mechanism against the accumulation of bile acids is the downregulation of bile acid uptake systems (24, 36, 40, 48) . Several models of cholestasis, such as bile acid feeding (10, 44) , bile duct ligation (9, 12) , or endotoxinemia (14, 31) showed downregulation of both Ntcp mRNA and protein levels in mouse and rat.
The exact molecular mechanism of decreased NTCP/Ntcp expression in cholestasis is unresolved. The rat Ntcp gene has been reported to be downregulated by the transcriptional repressor small heterodimer partner (SHP) 1 due to its interference with retinoid activation of the retinoid X receptor/retinoic acid receptor dimer (RXR␣/RAR␣) (7, 8) . However, the role of SHP is debatable. Bile acid feeding decreases Ntcp expression to the same degree in SHP knockout (SHP Ϫ/Ϫ ) mice as in SHP ϩ/ϩ mice, indicating that bile acids can repress the Ntcp gene through SHP-independent mechanisms (43) . Such mechanisms could include activation of the xenobiotic pregnane X receptor (PXR), activation of the c-Jun NH 2 -terminal kinase, or bile acid-mediated repression of the transcriptional activator hepatocyte nuclear factor-1␣ (HNF1␣) (20, 43) . Whereas several mechanisms that regulate the rat Ntcp gene have been identified (7, 8, 11, 22, 39) , little is known about the regulation of the NTCP/Ntcp gene in human and mouse. It is unknown, for instance, whether HNF1␣ and RXR␣/RAR␣ have the same activating effect on human and mouse NTCP/Ntcp as on rat Ntcp (7, 8, 22) .
To compare the transcriptional regulation of the human and mouse NTCP/Ntcp promoter with that of rat Ntcp, we isolated the 5Ј-regulatory regions of the human and mouse genes and compared sequences with the rat gene by computer alignment. A highly conserved sequence was identified that contained several cis-acting elements previously shown to regulate the rat Ntcp gene. We report the first in vitro characterization of the human and mouse NTCP/Ntcp promoters compared with the rat and show that the role of liver-enriched transcription factors and nuclear receptors in governing the transcriptional regulation of the NTCP/ Ntcp gene differs considerably between species.
MATERIALS AND METHODS
Plasmid construction. Fragments of the 5Ј-region of the human, mouse, and rat NTCP/Ntcp genes (Table 1) were amplified from genomic DNA (PfuTurbo DNA polymerase Stratagene, Amsterdam, Netherlands) and cloned into the luciferase reporter gene vector pGL3-Basic or pGL2-Enhancer (Promega Catalys, Wallisellen, Switzerland). Rat deletional constructs were generated by PCR (Table 1) from the original Ra-Luc construct and cloned into pGL3-Basic. Site-directed mutagenesis of the rat HNF1␣ site was performed as described previously (18) . Sequence identity of all constructs was verified by sequence analysis. Plasmid DNA was prepared using the Qiagen system (Basel, Switzerland).
Cell culture and reporter gene assay. Huh7 and chicken hepatoma (LMH) cells were cultured and transfected as described (20, 21) . In case of ligand treatment, the following ligands were added 18 h after transfection:
or DMSO, and/or ethanol as controls.
Electrophoretic mobility shift assays. Dimerized oligonucleotides (Microsynth, Balgach, Switzerland) with sequences corresponding to Fig. 1 . Analysis of the conserved 5Ј-regulatory region of the human, mouse, and rat NTCP/Ntcp gene. Using computer analysis, a highly conserved region that spans the complete 5Ј-untranslated region (UTR) and parts of the promoter was found in the human, mouse, and rat NTCP/Ntcp genes. Despite an overall sequence identity of up to 80%, major differences were found in the distribution of potential transcription factor recognition sites. Putative recognition sites are outlined. The human NTCP gene sequence is shown in capital letters (lower cases in mouse and rat; Ntcp indicate nonconserved nucleotides compared with the human sequence). *Start of the published NTCP/Ntcp cDNA sequences. Translated sequences are shown in bold. the NTCP/Ntcp gene or a perfect HNF3␤ binding site (Table 1) were labeled with [␥-32 P]adenosine triphosphate (3,000 Ci/mmol; Amersham Pharmacia Biotechnology, Dübendorf, Switzerland) using T4 polynucleotide kinase (Stratagene). For gel mobility shift assays, 2 l of in vitro translated HNF1␣ protein (TnT Quick coupled transcription/translation system; Promega Catalys) or 5 l Huh7 or HepG2 nuclear extracts were incubated as described previously (20, 21) . HNF3␤ (sc-6554), HNF4␣ (H-171), and RXR␣ (D-20) antibodies were from Santa Cruz Biotechnology (Heidelberg, Germany).
Statistical analysis. Reporter gene activities are expressed as the means Ϯ 1 SE of four to eight individual transfection experiments. All data were reproduced at least once using two different preparations of plasmid DNA.
RESULTS
Isolation of the human, mouse, and rat NTCP/Ntcp 5Ј-regulatory region. To identify conserved regions in the NTCP/ Ntcp gene, we first analyzed the human NTCP gene sequence using the computer program rVista (http://dcode.berkeley.edu/ rvista/). This program simultaneously searches the major transcription factor binding site database Transfac and uses global sequence alignment. In addition to the NTCP/Ntcp coding region, we found a second region that is highly conserved among human, mouse, and rat. This conserved region spans the complete 5Ј-untranslated region (UTR) as well as certain parts of the promoter, specifically nt Ϫ124 to ϩ83 in the human gene, nt Ϫ131 to ϩ58 in the mouse gene, and nt Ϫ53 to ϩ135 in the rat gene ( Figs. 1 and 2A) . Analysis of the conserved region revealed 72% sequence identity between human and mouse, 65% sequence identity between human and rat, and 80% sequence identity between mouse and rat. Potential transcription factor recognition sites shown in Fig. 1 were localized using the program Mat Inspector (Genomatix Software, Munich, Germany). Despite the overall sequence identity of up to 80%, we found major differences in the distribution of potential binding sites.
To compare the transcriptional regulation of the conserved 5Ј-regulatory region between species, appropriate fragments were PCR amplified from genomic DNA and cloned into the luciferase reporter vector pGL3-Basic. Constructs Hu-Luc, Mo-Luc, and Ra-Luc showed sequence identity with the accession numbers AF184235, AF190698, and L76612, respectively. In transfected Huh7 hepatoma cells, all constructs showed relevant luciferase activity compared with the promoterless control vector pGL3-Basic (Fig. 2B) .
Regulation of the NTCP/Ntcp gene by HNF1␣ and CEBP-␤. The rat Ntcp gene contains a highly conserved HNF1␣ recognition site located within the transcription start site, previously shown to bind HNF1␣ (22, 39) . A 4-bp insertion in the corresponding DNA sequence of the human and mouse NTCP/ Ntcp gene results in a disrupted HNF1␣ binding site but creates a consensus motif for the CCAAT/enhancer binding protein-␤ (CEBP-␤; Fig. 1 ). To assess the effect of HNF1␣ and CEBP-␤ on the different NTCP/Ntcp reporter constructs, expression vectors were cotransfected. Coexpressed HNF1␣ led to a 3.5-fold increase in rat promoter activity, whereas CEBP-␤ did not affect the rat Ntcp promoter (Fig. 3 , A and C). Conversely, the human and mouse NTCP/Ntcp constructs were not activated by HNF1␣ (Fig. 3A) , whereas CEBP-␤ increased luciferase activity by 40% (Fig. 3C) .
Absence of HNF1␣ binding to the human and mouse sequence was further supported by mobility shift assays. Only a rat-derived oligonucleotide (Table 1 ) was able to bind in vitro translated HNF1␣ protein (Fig. 3B ). The specificity of the complex was confirmed by competition and supershift analyses. No binding occurred using the corresponding sequence of the human or mouse NTCP/Ntcp genes.
HNF3␤ represses NTCP/Ntcp promoter function. HNF3␤ represents the only transcription factor with conserved binding sites in the 5Ј-regulatory region of the human, mouse, and rat NTCP/Ntcp genes ( Fig. 1) . In cotransfection experiments, HNF3␤ decreased luciferase activity of all promoter constructs (Hu-Luc Ϫ66%, Mo-Luc Ϫ41%, Ra-Luc Ϫ64%), suggesting that HNF3␤ may directly repress the NTCP/Ntcp gene (Fig.  4A ). To verify that HNF3␤ binds to the 5Ј-regulatory region, electrophoretic mobility shift assays were performed using labeled oligonucleotides that corresponded to the HNF3␤-I binding motif of the human and rodent genes ( Fig. 1) or to a perfect HNF3␤ binding site (perHNF3␤ in Table 1 ). In the presence of nuclear extracts from Huh7 cells, a specific DNAprotein complex was formed with both the human and rodent binding motif (Fig. 4B) . This complex was competed off in the presence of excess unlabeled human and mouse or rat oligonucleotides, respectively. Using a labeled perHNF3␤ oligonucleotide, complex formation was again competed off by the human and rodent binding motifs, whereas a mutated sequence (mutHNF3) did not inhibit (Fig. 4C) . Specificity of the DNAprotein complexes formed with both the NTCP/Ntcp-derived binding motifs as well as the perHNF3␤ binding motif was confirmed by supershift analyses (Fig. 4, B and C) .
The nuclear receptors RXR␣/RAR␣ and HNF4␣ selectively activate the rat Ntcp construct. The nuclear receptor heterodimer RXR␣/RAR␣ is an important activator of the rat Ntcp gene (7, 22, 26) . The RXR␣/RAR␣ response element is part of the conserved region and extends from nt Ϫ56 to Ϫ37 in the rat sequence. Computer analysis of the conserved 5Ј-regulatory region failed to identify an RXR␣/RAR␣ binding site in the human and mouse NTCP/Ntcp genes. In accordance with the computer prediction, only the rat but not the human or mouse NTCP/Ntcp constructs were induced by ligand activated RXR␣/RAR␣ (Fig. 5A) . Of note, a putative binding site for HNF4␣ is located within the RXR␣/RAR␣ sequence. Coexpressed HNF4␣ increased the activity of the rat Ntcp promoter construct twofold, suggesting a possible functional role of the identified consensus motif. In contrast, HNF4␣ had no effect on the activity of the human or mouse NTCP/Ntcp constructs Coexpressed HNF1␣ led to a 3.5-fold increase in rat Ntcp promoter activity (Ra-Luc), whereas the human and mouse NTCP/Ntcp promoter constructs were not affected. B: oligonucleotides derived from conserved regions of the human, mouse, or rat promoter sequences that corresponded to the HNF1␣ binding site in the rat gene were radioactively labeled and incubated with in vitro-translated HNF1␣ protein. Only the oligonucleotide derived from the rat sequence formed a DNA-protein complex. Competition experiments using the 32 P-labeled rat oligonucleotide and a 100-fold excess of unlabeled rat, human, or mouse oligonucleotides showed that the human and mouse oligonucleotides did not inhibit protein binding, whereas the unlabeled rat oligonucleotide inhibited the formation of a DNA-protein complex. Addition of an antibody raised against HNF1␣ completely abolished complex formation, whereas a control antibody against the glucocorticoid receptor (GR) had no effect. C: cells were cotransfected with the indicated NTCP/Ntcp promoter constructs and either a CEBP-␤ expression plasmid or empty pBluescript vector (Carrier). Coexpressed CEBP-␤ led to a moderate increase in human and mouse NTCP/Ntcp promoter activity, whereas the rat construct and the promoterless Basic vector were not affected.
( Fig. 5B) , despite the presence of a consensus motif at nt Ϫ43/Ϫ26 of the human sequence.
To investigate whether HNF4␣ activates rat Ntcp through direct binding to the putative binding site or through an indirect mechanism such as induction of HNF1␣ (45), two additional rat promoter deletional constructs (Ϫ12-Ra-Luc and ϩ28-RaLuc) and a construct containing a mutated HNF1␣ binding site (mutH1-Ra-Luc) were generated (Fig. 6A) . As shown in Fig.  6B , coexpressed HNF4␣ again increased the activity of the initial rat Ntcp promoter construct (Ra-Luc). In contrast, deletion of the HNF4␣ binding site in constructs Ϫ12-Ra-Luc and ϩ28-Ra-Luc abolished this activation, whereas the full-length construct with a mutated HNF1␣ site was still activated (Fig.  6B) . These data suggested that HNF4␣ transactivates through direct binding to the rat Ntcp promoter. To verify binding of HNF4␣, electrophoretic mobility shift assays were performed using labeled oligonucleotides that corresponded to the HNF4␣-RXR␣/RAR␣ binding motif of the rat Ntcp gene (Fig.  1, Table 1 ). In the presence of nuclear extracts from HepG2 cells, two specific DNA-protein complexes were formed with the rat binding motif (Fig. 6C) . These complexes were competed off in the presence of excess unlabeled rat HNF4␣ oligonucleotide but not by unlabeled human or mouse oligonucleotides, respectively. Specificity of the DNA-protein complexes formed with the rat HNF4␣-RXR␣/RAR␣ binding motif was confirmed by supershift analyses (Fig. 6C) . Addition of antibody against HNF4␣ resulted in a supershift (top arrow in Fig. 6C ) and attenuated the formation of the HNF4␣ DNAprotein complex (bottom arrow in Fig. 6C ). Addition of antibody against RXR␣ abolished formation of the RXR␣/RAR␣ DNA-protein complex (middle arrow in Fig. 6C ). These data confirmed binding of both factors to the HNF4␣-RXR␣/RAR␣ response element in the rat Ntcp promoter.
Neither bile acids nor the transcriptional repressor SHP inhibit baseline NTCP/Ntcp promoter function. The rat Ntcp gene is thought to be repressed by bile acids via induction of the small heterodimer partner SHP through bile acid-activated farnesoid X receptor (FXR). To test this hypothesis, we used the LMH cell line, previously shown to possess conserved FXR signaling pathways (17, 21) . CDCA treatment of LMH cells transfected with the different NTCP/Ntcp promoter constructs resulted in only a slight decrease in luciferase activity of the mouse and rat promoters. In contrast, the bile acid DCA decreased the activity of the rat but not the mouse promoter, indicating that only the rat promoter is in any way responsive to bile acids (Fig. 7A) . In contrast, a promoter construct of the human HNF1␣ gene, previously shown to contain a classic "bile acid response element" (20) , was markedly suppressed as Coexpressed HNF3␤ repressed luciferase activity in all species, whereas it had no effect on the promoterless reporter vector (pGL2). B: HNF3␤ binds to a consensus motif conserved between species. Electrophoretic mobility shift assays were performed using 32 P-labeled oligonucleotides corresponding to the human or rodent HNF3␤ binding sites. The addition of nuclear extracts from Huh7 cells resulted in a DNA-protein complex (bottom arrow) that was competed off in the presence of excess unlabeled human (Hu) and rodent (Mo/Ra) oligonucleotides, respectively. The addition of antibody against HNF3␤ led to a supershift (top arrow). C: to confirm the specificity of HNF3␤ binding, an oligonucleotide containing a perfect consensus motif for HNF3␤ was incubated with nuclear extracts from Huh7 cells, resulting in a DNA-protein complex as expected (bottom arrow). This complex was supershifted by the addition of antibody against HNF3␤ (top arrow). The addition of excess unlabeled oligonucleotides corresponding to the sequence of the perfect consensus motif (perHNF3) or the consensus motifs in the human or rodent NTCP/Ntcp genes competed off DNA-protein complex formation. In contrast, an oligonucleotide containing a mutated HNF3␤ binding site (mutHNF3) had no effect on complex formation. expected (Fig. 7A) , confirming that the bile acid-controlled gene regulatory cascade was functional in LMH cells. It is of note that the bile acid CA, which has not been described as a functional FXR ligand (29) , had no effect on any promoter construct analyzed (Fig. 7A) .
To further elucidate the role of SHP, Huh7 cells were cotransfected with the NTCP/Ntcp constructs and an expression plasmid coding for SHP. As a positive control, we again employed the HNF1␣ construct, which is transcriptionally repressed by SHP (20) . As shown in Fig. 7B , baseline promoter function of all three NTCP/Ntcp constructs was not affected by SHP. Because one mechanism by which SHP represses transcription is through decreased transactivation of the target gene by the liver receptor homolog 1 [LRH; also called fetal transcription factor (FTF) in humans] (2, 13, 28), we studied whether cotransfection of LRH or FTF activates the NTCP/ Ntcp constructs. Coexpression of LRH or FTF had no detectable effect on NTCP/Ntcp promoter activity (data not shown). Taken together, these results indicate that neither CDCA nor SHP repress the NTCP/Ntcp gene promoter via a classic bile acid response element, as shown for certain bile acid-synthesizing enzyme genes as well as for the human HNF1␣ gene (6, 13, 20, 28, 47) . Decreased expression of Ntcp in rat models of cholestasis is probably not attributable to a direct repressive effect of bile acids but rather to indirect effects such as cytokine-mediated inhibition of RXR␣/RAR␣ or bile acidmediated repression of HNF1␣ and HNF4␣ (5, 7, 20) .
DISCUSSION
This study reports the initial characterization of the 5Ј-regulatory region of the human and mouse NTCP/Ntcp gene, which codes for the major bile salt uptake system of mammalian liver. A conserved region with a sequence identity of up to 80% among the human, mouse, and rat NTCP/Ntcp genes spans part of the promoter and the complete 5Ј-untranslated region. Sequence alignment of this conserved region revealed major differences in the distribution of potential transcription factor binding sites (Fig. 1) . The key findings of our study can be summarized as follows: 1) the conserved region in the promoter of the rat Ntcp gene, but not of human or mouse NTCP/Ntcp, is directly transactivated by HNF1␣ and HNF4␣; 2) human and mouse NTCP/Ntcp are activated by CEBP-␤; 3) the only transcription factor that binds to a conserved motif in all three species is HNF3␤, which represses NTCP/Ntcp promoter activity in cotransfection assays; 4) the previously described RXR␣/RAR␣ binding site in the rat Ntcp promoter is not present at the corresponding position in the human or mouse promoter; and 5) baseline function of the conserved NTCP/Ntcp promoter region in all three species is not repressed by the bile acid CDCA and is not influenced by coexpression of SHP.
To examine the regulation of the NTCP/Ntcp gene, we first studied HNF1␣, a known regulator of basolateral bile acid transporter genes (35) . The rat Ntcp gene contains a highly conserved HNF1␣ response element, previously shown to bind HNF1␣ (22) . In this study, we showed that coexpression of HNF1␣ increases rat Ntcp promoter activity, confirming its role as a transcriptional activator (Fig. 3) . However, neither the human nor the mouse NTCP/Ntcp promoter constructs were activated by HNF1␣. Mobility shift assays indicated that the 4-bp insertion in the human and mouse NTCP/Ntcp promoter region disrupts the HNF1␣ binding site present in the rat, explaining the lack of activation. In place of the HNF1␣ site, a consensus motif for the liver-enriched transcription factor CEBP-␤ is present in the human and mouse NTCP/Ntcp gene. Both human and mouse constructs are activated by CEBP-␤ in cotransfection assays, whereas the rat Ntcp construct shows no induction (Fig. 3C) . Members of the CEBP family have been implicated in regulating the differentiation of certain mammalian cells, including adipocytes and hepatocytes (1, 30, 34) . CEBP-␤ could, therefore, contribute to the liver-specific expression of the NTCP/Ntcp gene in human and mouse.
Notwithstanding these data, the HNF1␣ knockout mice reported by Shih et al. (35) , were shown to have almost absent Ntcp expression, suggesting that HNF1␣ binds at a different site in the mouse Ntcp gene. Generally, HNF1␣ can activate gene expression either through binding to a site near the transcription start site, as shown for the SLCO1B1 (protein name OATP1B1, formerly called OATP-C/OATP2), ASBT (SLC10A2), and NPT1 genes (3, 18, 19, 35) , or through binding to sites that function as enhancers and are often located within intronic sequences, as shown for the aldolase B, HNF4, and -tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid (TTNPB)} resulted in a 2-fold activation of the rat Ntcp reporter construct, whereas neither the human and mouse NTCP/Ntcp constructs nor the control (Basic) showed any response. B: cotransfection of an HNF4␣ expression plasmid activated the rat Ntcp promoter construct 2-fold, whereas it had no effect on the human and mouse NTCP/Ntcp constructs or the Basic vector. w/o, Without.
NPT1 genes (3, 15, 27) . Using a computer approach, we screened the proximal 1,000 bp of the promoter and all intronic sequences of the human and mouse NCTP/Ntcp genes for potential HNF1␣ binding sites. Although no HNF1␣ binding site was found within the promoter regions, we localized highly conserved motifs within intronic sequences (introns 1, 2, and 4 in human NTCP, intron 2 in mouse Ntcp). The exact role of these intronic HNF1␣ binding sites remains to be investigated.
Of note, the HNF1␣ Ϫ/Ϫ strain generated by Pontoglio et al. (32) in our hands had almost normal Ntcp expression in Western blot analysis (data not shown). In contrast, expression of the apical sodium-dependent bile acid transporter (Asbt, Slc10a2) was strongly decreased (data not shown). In addition, we found that luciferase constructs of the rat Ntcp promoter containing the 5Ј-UTR but no HNF1␣ binding site were still active (Fig. 6B) , suggesting that HNF1␣ is not critical for baseline promoter activity. In view of these discrepancies, the exact role of HNF1␣ in regulating the NTCP/Ntcp gene remains to be elucidated.
HNF3␤ was the only factor with conserved binding sites in all species (Fig. 1) . Coexpressed HNF3␤ repressed the NTCP/ Ntcp promoter constructs (Fig. 4A) , and binding of HNF3␤ to the HNF3␤-I consensus motif (Fig. 1) was verified by mobility shift assays (Fig. 4, B and C) . HNF3␤ is an essential transcription factor during embryonic development and is thought to be a genetic initiator of the hepatic differentiation program (37, 46) . However, the function of HNF3␤ in adult liver is not fully understood. Ntcp mRNA levels are substantially reduced in transgenic mouse hepatocytes overexpressing HNF3␤, and serum bile acid levels are increased 50-fold (33, 38) . In humans, increased expression of HNF3␤ in hepatocellular carcinomas is associated with decreased NTCP expression in Northern blot and immunofluorescence analyses (23, 41) . These results suggest that HNF3␤ may repress NTCP/Ntcp gene expression in vivo.
Several studies (25, 40) have suggested a repressive effect of bile salts on the NTCP/Ntcp gene in view of the consistent decrease in NTCP/Ntcp expression that is found in cholestasis. In the case of the rat Ntcp gene, the repressive effect of bile acids has been proposed to involve inhibition of retinoid activation of the nuclear receptor dimer RXR␣/RAR␣ by the transcriptional repressor SHP (8) . The RXR␣/RAR␣ binding element in the rat Ntcp gene is part of the conserved Fig. 6 . HNF4␣ binds to the rat Ntcp gene. A: design of rat deletional constructs (Ϫ12-Ra-Luc and ϩ28-Ra-Luc) and a construct with a mutated HNF1␣ binding site (mutH1-Ra-Luc). Nucleotide ϩ1 denotes the transcription start site, the asterisk symbolizes the translation start site of the rat Ntcp gene. B: Huh7 cells were cotransfected with the rat Ntcp promoter constructs and either an HNF4␣ expression plasmid or pBluescript (Carrier) as a control. Coexpressed HNF4␣ activated rat Ntcp promoter constructs containing the HNF4␣ binding site (Ra-Luc, mutH1-Ra-Luc), whereas it had no effect on constructs lacking the HNF4␣ binding site (Ϫ12-Ra-Luc and ϩ28-Ra-Luc) or on the promoterless reporter vector (Basic). C: HNF4␣ binds to the HNF4␣ consensus motif of the rat Ntcp gene. Electrophoretic mobility shift assays were performed using 32 P-labeled oligonucleotides corresponding to the rat HNF4␣-RXR␣/RAR␣ binding site. The addition of nuclear extracts from HepG2 cells resulted in 2 DNA-protein complexes (HNF4␣, RXR␣/RAR␣) that were competed off in the presence of excess unlabeled rat (Ra) oligonucleotide but not by oligonucleotides derived from the corresponding sequences in the human or mouse NTCP/Ntcp promoters. The addition of antibody against HNF4␣ led to a supershift (top arrow). Addition of antibody against RXR␣ abolished formation of the RXR␣/RAR␣ DNA-protein complex (middle arrow). region ( Fig. 1) . In the human and mouse genes, the binding site is disrupted by nucleotide exchanges (Fig. 1) . Accordingly, only the rat Ntcp reporter construct is activated by retinoid ligand treatment, whereas the human and mouse promoters show no response (Fig. 5A ). This probably represents a major difference in the regulation of the rat compared with the human and mouse NTCP/Ntcp genes, because the repressive effects of bile acids, cholestasis, and cytokines on Ntcp expression have been largely attributed to decreased transactivation by RXR␣/RAR␣ (7, 8, 26) . Clearly, binding of RXR␣/RAR␣ to a sequence that is not part of the conserved 5Ј-regulatory region cannot be excluded for the human and mouse genes. The nucleotide sequence spanning the RXR␣/RAR␣ site in the rat promoter also represents an HNF4␣ binding site, as shown by cotransfection and mobility shift assays in this study (Fig. 6) . One can only speculate as to whether, in vivo, both factors, RXR␣/RAR␣ and HNF4␣, are corequisite for rat Ntcp gene expression or whether they have distinct functions under different physiological conditions.
Although bile acids were previously reported to inhibit retinoid activation of RXR␣/RAR␣ in the rat through an SHP-mediated mechanism, a direct suppressive effect of SHP on the Ntcp promoter has not been shown in an in vitro system. We, therefore, tested the hypothesis that SHP directly represses NTCP/Ntcp promoter activity. As an assay system, we employed LMH cells that possess a conserved FXR signaling pathway and have been used extensively as a model for ligand-dependent activation of endogenously expressed nuclear receptors (17, 18, 21) . Using the LMH cell culture system, we did not find relevant repression of NTCP/ Ntcp promoter activity by treatment of cells with the FXR ligands CDCA and DCA (Fig. 7A) . In addition to the lack of repression by bile acids, overexpression of the nuclear receptor SHP was also without effect on the NTCP/Ntcp constructs (Fig. 6B) . In contrast, a promoter construct of the HNF1␣ gene, previously shown to be negatively regulated by bile acids through an SHP-mediated pathway (20) , was repressed by both bile acids (CDCA, DCA) and SHP as expected. The lack of a repressive effect of cotransfected SHP on the NTCP/Ntcp constructs is in agreement with in vivo studies in SHP Ϫ/Ϫ mice. CA feeding represses Ntcp expression to the same degree in SHP Ϫ/Ϫ mice as in wildtype SHP ϩ/ϩ mice, indicating that the repressive effect of bile acids on Ntcp expression is not directly mediated by SHP (43) . It is likely that other mechanisms are responsible for the negative regulation of NTCP/Ntcp by bile acids. One such mechanism could be the induction of cytokines by bile acids (4), because several transcription factors such as ligand-activated RXR␣/RAR␣, HNF1␣, and HNF4␣, which are important for the expression of rat Ntcp and other liver-specific genes, are suppressed by cytokines (39, 42) . Because the rat Ntcp promoter binds and is transactivated by HNF4␣ (Figs. 1 , 5B, and 6), decreased expression of rat Ntcp in cholestasis could be attributable to the known repressive effect of bile acids and cytokines on nuclear HNF4␣ levels (20, 42, 47) . Moreover, bile acids block the association of HNF4␣ with its transcriptional coactivators, thereby inhibiting the transactivation of target genes of HNF4␣ (5) . The latter mechanism has been shown to be a major pathway by which bile acids repress the cholesterol 7␣-hydroxylase gene (5). 100 M) , or DMSO as a control. CDCA treatment resulted in a 30% decrease, and DCA treatment resulted in a 25% decrease in rat Ntcp luciferase reporter activity, whereas the human and mouse constructs and the promoterless luciferase vector (Basic) did not show a comparable response. As a control, a promoter construct of the human HNF1␣ gene was shown to be repressed by CDCA and DCA as expected. The bile acid CA, which is not an farnesoid X receptor ligand, did not change promoter activity. B: Huh7 cells were cotransfected with the indicated NTCP/Ntcp promoter constructs and either an expression plasmid coding for the nuclear receptor SHP or pBluescript vector (Carrier). Coexpressed SHP did not affect NTCP/Ntcp promoter activity in any species, whereas the SHP-responsive promoter of the human HNF1␣ gene was repressed as expected.
In summary, this study shows that the liver-enriched transcription factors HNF1␣, CEBP-␤, HNF3␤, and HNF4␣ and the nuclear receptor dimer RXR␣/RAR␣ have an important but species-specific function in the regulation of the NTCP/Ntcp gene. The transcriptional regulation of NTCP/Ntcp thus differs among human, mouse, and rat. Of note, the conserved 5Ј-regulatory region of the NTCP/Ntcp gene does not possess a direct bile acid response element, suggesting that bile acids regulate NTCP/Ntcp expression through indirect mechanisms.
